◀ Back to BCR

BCR — MAP3K1

Text-mined interactions from Literome

Nawata et al., Oncogene 2003 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) : These results indicate that MEKK1 is a downstream target of Bcr-Abl, and that the antiapoptotic effect of Bcr-Abl in chronic myelogenous leukemia cells is mediated via the MEKK1-NF-kappaB pathway
Nakamura et al., Oncogene 2005 (Cell Transformation, Neoplastic...) : Bcr-Abl enhanced MEKK1 expression in ES transfectants, as it does in other Bcr-Abl transformed cells